Maack et al. [70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class.
the choice of β blocker for the treatment of chronic HF should be evidence-based. In this regard, only two agents should be considered in the United States: carvedilol and metoprolol CR/XL.
Administration of beta-blockers alone in the setting of pheochromocytoma may cause a paradoxical increase in BP. Limited available data from published literature report that metoprolol is present ...
Metoprolol is a beta 1-selective (cardioselective ... Pheochromocytoma (initiate with an alpha-blocker first). Surgery. May mask signs and increased risk for hypoglycemia. Hyperthyroidism.
Metoprolol, acebutolol ... combining them with beta-blockers, which are more commonly linked to weight gain, may cause weight gain. Calcium channel blockers used to treat heart-related conditions ...